학술논문
GLANCE
Document Type
Article
Author
Source
Neurology (Ovid); March 2009, Vol. 72 Issue: 9 p806-812, 7p
Subject
Language
ISSN
00283878; 1526632X
Abstract
To evaluate the safety and tolerability of natalizumab when added to glatiramer acetate (GA) in patients with relapsing multiple sclerosis. The primary outcome assessed whether this combination would increase the rate of development of new active lesions on cranial MRI scans vs GA alone.